HOME >> MEDICINE >> NEWS
Making headway against hepatitis C: SLU study shows new drug combo effective in nonresponders

ST. LOUIS -- Saint Louis University Liver Center scientists are presenting research today on a more effective way to treat hepatitis C patients who have been unresponsive to current drug therapies.

They have shown that a cocktail of ribavirin and Infergen, a highly potent Interferon, is nearly twice as effective at controlling hepatitis C than standard treatments.

They are sharing their findings at the annual American Association for the Study of Liver Diseases meeting in Boston.

"The results are promising," says Bruce R. Bacon, M.D., principal investigator and director of the division of gastroenterology and hepatology at Saint Louis University School of Medicine. "This group of non-responders is a very challenging population to treat, and we found that patients who followed through with the therapy had a response nearly twice that of previous trials looking at this population."

Saint Louis University Liver Center researchers led a study of more than 500 patients with hepatitis C at 40 sites, 77 percent of whom had advanced fibrosis. Fourteen percent of patients taking 9mcg of Infergen daily and 20 percent taking 15 mcg were virus negative after six months.

A quarter of the non-cirrhotic patients receiving Infergen were also virus negative after 24 weeks. The optimal response to antiviral therapy is for the hepatitis C viral RNA to become undetectable on treatment and to remain undetectable for at least another six months off therapy; this is referred to as a sustained virologic response, essentially a cure of the disease. Rates of sustained virologic response are still to be determined in this ongoing study.

Infergen is a highly potent type of interferon currently used for adult patients with chronic hepatitis C three times a week, Bacon says. This trial is expected to be completed in 2007.

An estimated 3.9 million Americans have hepatitis C. About 250,000 who have been offered therapy are
'"/>

Contact: Rachel Otto
ottorl@slu.edu
314-977-8018
Saint Louis University
30-Oct-2006


Page: 1 2

Related medicine news :

1. Making science personal: Lilly Oncology to unveil 76 studies at ASCO 2007
2. Making old hearts young again
3. Making sense of the world through a cochlear implant
4. Making heart surgery intervention safer
5. Making a healthy lunch a greater national priority
6. Making multiple lifestyle changes is beneficial, achievable in lowering high blood pressure
7. Making the most of our precious nursing resources
8. Making the best decisions when faced with the risks of premature delivery
9. Making primary health care work: New research
10. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
11. DNA vaccine against multiple sclerosis appears safe, potentially beneficial

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/15/2018)... ... September 14, 2018 , ... Today, ... will showcase the innovative work being done within rare diseases research, diagnostics, and ... those living with rare diseases. , Clay Matthews, Super Bowl-winning ...
(Date:9/13/2018)... (PRWEB) , ... September 13, 2018 , ... Pulsara is ... Health IT + Revenue Cycle Conference on September 19-22 in Chicago. Dr. Woodson, ... panels as well as a talk titled, “Your Clinical Communication & Collaboration (CC&C) is ...
(Date:9/12/2018)... ... 2018 , ... Donaldson Plastic Surgery has been included on the Inc. 5000 ... 50 list of central Ohio's fastest growing businesses. The plastic surgery practice was ranked ... It is the only medical practice and plastic surgery office to make the regional ...
(Date:9/7/2018)... , ... September 07, 2018 , ... ... College District , the only OSHA authorized OTI Education Center headquartered in Northern ... assist employees who feel they have experienced retaliation in response to engaging in ...
(Date:9/2/2018)... ... September 02, 2018 , ... Eaton ... social change. The hotel itself, which opened this week, inspires creativity and innovation ... or more. , Eaton Hotel DC currently features 209 hotel rooms, a wellness ...
Breaking Medicine News(10 mins):
(Date:9/13/2018)... ... September 13, 2018 , ... NCPDP ... to test and ensure correct implementation of the NCPDP SCRIPT Standard Version 2017071 ... important functionality and transactions identified by the industry as vital enhancements in improving ...
(Date:9/12/2018)... ... September 12, 2018 , ... ... Cycle Conference in Chicago, IL, from September 19-22. The IT + Revenue Cycle ... patient engagement and empowerment with the use of Precision Virtual Reality™ medical visualization ...
(Date:9/7/2018)... ... September 06, 2018 , ... This year, the California Society of Plastic Surgeons ... of: IDEAL IMPLANT® - Seven-Year Clinical Trial Results at the 68th CSPS Annual Meeting. ... upcoming ASPS (American Society of Plastic Surgeons) meeting in Chicago this fall. , “I ...
Breaking Medicine Technology:
Cached News: